Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he delves into pivotal studies such as CheckMate 914 Part B and KEYNOTE-564, explorin ... Show More
Sep 22
Episode 297: Keto Diet and Cancer With Thomas Seyfried
In this thought-provoking episode, Chadi Nabhan sits down with Thomas Seyfried, PhD, professor of biology at Boston College, to explore his controversial and unconventional views on cancer metabolism, the ketogenic diet, and the role of sugar in cancer development. Dr. Seyfried e ... Show More
46m 45s
Sep 15
Episode 296: All Things Sarcoma With Neeta Somaiah
Neeta Somaiah, MD, of The University of Texas MD Anderson Cancer Center, provides a comprehensive overview of bone and soft tissue sarcomas, exploring how molecular classification and histology guide treatment decisions, the major therapeutic breakthroughs and drug approvals that ... Show More
43m 18s
Sep 8
Episode 295: Integrative Approaches to Breast Cancer With Michael Karlfeldt
Chadi speaks with Michael Karlfeldt, ND, PhD, a board-certified naturopathic doctor, integrative medicine expert, and author of Breast Cancer Breakthrough: Integrating Conventional & Natural Medicine for True Healing, about evidence-informed complementary approaches to breast can ... Show More
42m 53s
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
57m 23s
Feb 2024
Key Advances in Prostate, Kidney, and Bladder Cancers at GU24
<p>Drs. Neeraj Agarwal and Todd Morgan discuss CONTACT-02, KEYNOTE-564, CheckMate-67T, and other notable studies featured at the 2024 ASCO Genitourinary Cancers Symposium, as well as additional key abstracts in prostate, kidney, and bladder cancers that will significantly influen ... Show More
30m 6s
Sep 2024
ESMO 2024 special: Prof. Kitamura shares results of JCOG1019 (BCa)
<p>In this podcast recorded live at ESMO 2024 in Barcelona, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talked to Prof. Hiroshi Kitamura (JP) about his presentation on the JCOG1019 study results: An open-label, non-inferiority, randomised phase III study comparing the effe ... Show More
10 m
Jan 2024
What's New in Prostate Cancer, RCC, and mUC at GU24
<p>Drs. Neeraj Agarwal and Jeanny Aragon-Ching discuss several key abstracts to be presented at the 2024 ASCO GU Cancers Symposium, including sequencing versus upfront combination therapies for mCRPC in the BRCAAway study, updates on the CheckMate-9ER and CheckMate-214 trials in ... Show More
25m 10s
<p class="MsoNormal" style="text-align: justify;"><span class= "normaltextrun"><span style= "font-size: 11.0pt; line-height: 107%; font-family: 'Calibri',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-theme-font: major-fareast; mso-ansi-language: EN-US; mso-f ... Show More
